Inventor
JILL M. STURDIVANT
Inventor
US
Overview
Patents· 9 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations36%
A61KPreparations for medical, dental or toiletry purposes28%
C07DHeterocyclic compounds24%
C07CAcyclic or carbocyclic compounds8%
C07JSteroids4%
PatentTitleYear
12,459,956Heterobicyclic carboxamides and uses thereof202512,018,012Aryl cyclopropyl-amino-isoquinolinyl amide compounds202411,891,376Aryl cyclopropyl-amino-isoquinolinyl amide compounds202411,707,460Ophthalmic compositions202311,691,950Isoquinoline-steroid conjugates and uses thereof202311,590,123Ophthalmic compositions202311,427,563Aryl cyclopropyl-amino-isoquinolinyl amide compounds202211,389,441Ophthalmic compositions202211,312,700Aryl cyclopropyl-amino-isoquinolinyl amide compounds2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2024Patents assigned to AERIE PHARMACEUTICALS INC (8)· patent assignee history
2022–2025Based in US· patent location history
2025Patents assigned to ALCON INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| AERIE PHARMACEUTICALS INC | 8 | 2022–2024 |
| ALCON INC | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 9 | 2022–2025 |